Suicide gene therapy for prostate cancer using a replication-deficient adenovirus containing the herpesvirus thymidine kinase gene

World Journal of Urology

Volumn 18, Issue 2, 2000, Pages 125-129

  Shalev, Moshe ^a   Miles, Brian J ^a   Thompson, Timothy C ^a   Kadmon, Dov ^a   Shalev, M ^a   Miles, B J ^a   Thompson, T C ^a   Ayala, G ^a   Butler, E B ^a   Aguilar Cordova, E ^a   Kadmon, D ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYMIDINE KINASE;

ADENOVIRUS; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENE THERAPY; GENE VECTOR; GENETICS; GROWTH, DEVELOPMENT AND AGING; HERPES SIMPLEX VIRUS; HUMAN; MALE; METHODOLOGY; PHASE 1 CLINICAL TRIAL; PROSTATE TUMOR; REVIEW;

ADENOVIRIDAE; CLINICAL TRIALS, PHASE I; GENE EXPRESSION REGULATION, VIRAL; GENE THERAPY; GENETIC VECTORS; HUMANS; MALE; PROSTATIC NEOPLASMS; SIMPLEXVIRUS; THYMIDINE KINASE;

EID: 0034168329     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003450050184     Document Type: Article

References (33)

1. Andersen WF (1998) Human gene therapy. Nature 392: 25-30
2. Bi WL, Parysek LM, Warnick R, Stambrook PJ (1993) In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV-tk retroviral gene therapy. Hum Gene Ther 4: 725-731
3. Bramson JL, Hitt M, Addison CL, Muller WJ, Gauldie J, Graham FL (1996) Direct intratumoral injection of an adenovirus expressing interleukin-12 induces regression and longlasting immunity that is associated with highly localized expression of interleukin-12. Hum Gene Ther 7: 1995-2002
4. Brothman A, Peehl D, Pa tel A, McNeal J (1990) Frequency and pattern of karyotypic abnormalities in human prostate cancer. Cancer Res 50: 3795-3803
5. Caruso M, Pham-Nguyen K, Kwong YL, Xu B, Kosai KI, Finegold M, Woo SL, Chen SH (1996) Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma. Proc Natl Acad Sei USA 93: 11302-11306
6. Crook JM, Choan EGA, Robertson PS, Esche AB (1998) Serum prostate-specific antigen profile following radiotherapy
7. D'Amico AV, Hanks GE (1993) Linear regressive analysis using prostate-specific antigen doubling time for predicting tumor biology and clinical outcome in prostate cancer. Cancer 72: 26382643
8. Eastham AJ, Chen H-S, Sehgal I, Yang G, Timme TL, Hall JS, Woo LCS, Thompson CT (1996) Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models. Hum Gene Ther 7: 515-523
9. Pick J, Barker FGN, Dazin P, Westphale EM, Beyer EC, Israel MA (1995) The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro. Proc Natl Acad Sei USA 92: 11071-11075
10. Freeman SM, Abboud CN, Whartenby KA, Packman CH, Koeplin DS, Mooten FL, Abraham GN (1993) The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 53: 5274-5283
11. Freeman SM, Ramesh R, Shastri M, Munshi A, Jensen AK, Marrogi AJ (1995) The role of cytokines in mediating the bystander effect using HSV-TK xenogeneic cells. Cancer Lett 92: 167-174
12. Hall SJ, Mutchnik SE, Chen S-H, Woo SLC, Thompson TC (1997) Adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy leads to systemic activity against spontaneous and induced metastasis in an orthotopic mouse model of prostate cancer. Int J Cancer 70: 183-187
13. Hamel W, Magnelli L, Chiarugi VP, Israel MA (1996) Herpes simplex virus thymidine kinase/ganciclovir-mediated apoptotic death of bystander cells. Cancer Res 56: 2697-2702
14. Herman JR, Adler LH, Aguilar-Cordova E, Rojas-Martinez A, Woo S, Timme TL, Wheeler MT, Thompson TC, Scardino PT (1999) In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trial. Hum Gene Ther 10: 1239-1249
15. Kattan MW, Eastham JA, Stapleton AM, Wheeler TM, Scardino PT (1998) A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 90: 766-771
16. Link CJ Jr, Kolb EM, Muldoon RR (1995) Preliminary in vitro efficacy and toxicity studies of the herpes simplex thymidine kinase gene system for the treatment of breast cancer. Hybridoma 14: 143 147
17. Mufson MA, Belshe RB (1976) A review of adenovirus in the etiology of acute hemorrhage. J Urol 115: 191-194
18. Müllen CA, Coale MM, Löwe R (1994) Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild-type tumor. Cancer Res 54: 1503-1506
19. Mulligan RC (1993) The basic science of gene therapy. Science 260: 926-932
20. Namba H, Iwadate Y, Tagawa M, Kimura M, Shimizu H, Sato Y, Sueyoshi K, Sakiyama S (1996) Evaluation of the bystander effect in experimental brain tumors bearing herpes simplex virus-thymidine kinase gene by serial magnetic resonance imaging. Hum Gene Ther 7: 1847-1852
21. Nasu Y, Bangma CH, Hull GW, Lee H-M, Hu J, Wang J, McCurdy MA, Shimura S, Yang G, Timme TL, Thompson TC (1999) Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung métastases in an orthotopic model. Gene Ther 6: 338-349
22. Physicians' desk reference, 52nd edn (1998) Medical Economics, New York, p 2452
23. Prince MH (1998) Gene transfer: a review of methods and applications. Pathology 30: 335-347
24. Qian J, Bostwick D, Takashi S, Boreil T, Herath J, Lieber M, Jenkins R (1995) Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Cancer Res 55: 5408-5414
25. Ram Z, Walbridge S, Shawker T, Culver KW, Blaese RM. Oldfield EH (1994) The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats. J Neurosurg 81: 256-260
26. Ramesh R, Marrogi AJ, Munshi A, Abboud CM, Freeman SM (1996) In vivo analysis of the "bystander effect": a cytokine cascade. Exp Hematol 24: 829-838
27. Sakr WA. Macoska JA, Benson P, Grignon DJ, Wolman SR, Pontes JE, Crissman JD (1994) Allelic loss in locally metastatic, multisampled prostate cancer. Cancer Res 54: 3273-3277
28. Schmid H-P, Maibach R, Bernhard J, Hering F, Hanselman S, Gusset H, Morant R, Pestalozzi D, Castiglione M (1997) A phase II study of oral idarubicin as a treatment for metastatic hormone-refractory prostate carcinoma with special focus on prostate specific antigen doubling time. Cancer 79: 1703-1709
29. Simons WJ, Marshall FF (1998) The future of gene therapy in the treatment of urologie malignancies. Urol Clin North Am 25: 23 -38
30. Stratford-Perricaudet LD, Levrero M, Chasse JF, Perricaudet M, Briand P (1990) Evaluation of the transfer and expression in mice of an enzyme encoding gene using a human adenovirus vector. Hum Gene Ther 1: 241-256
31. Thompson TC, Park SH, Timme TL, Ren C. Eastham JA, Donehower LA, Bradley A, Kadmon D, Yang G (1995) Loss of p53 function leads to metastasis in ras + wye-initiated mouse prostate cancer. Oncogene 10: 869-879
32. Van der Eb MM, Cramer SJ, Vergouwe Y, Schagen FH, Van Krieken JH, Van der Eb AJ, Rinkes IH, Van de Velde CJ, Hoeben RC ( 1998) Severe hepatic dysfunction after adenovirusmediated transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administration. Gene Ther 5: 451458
33. Vile RG, Castleden S, Marshall J, Camplejohn R, Upton C, Chong H (1997) Generation of an antitumor immune response in a non-immunogenic tumor: HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a Thl-like profile of intratumoral cytokine expression. Int J Cancer 71: 267-274